Selecta Biosciences IPO Research Information

Selecta Biosciences IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Selecta Biosciences, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Selecta Biosciences	SELB - NASDAQ	$14.00-$16.00	$14.00	$15.00	5 Million	6/22/2016
Underwriter(s): UBS Investment Bank, Stifel
Co-Manager(s): Canaccord Genuity, Needham and Company
Industry: Health Care
Filing(s): Filed 2016-05-24 Terms added 2016-06-08

Selecta Biosciences Quote & Chart - Click for current quote - SELB

About Selecta Biosciences (adapted from Selecta Biosciences prospectus):
They are a clinical-stage biopharmaceutical company using our proprietary synthetic vaccine particle, or SVP, technology to discover and develop targeted therapies that are designed to modulate the immune system to effectively and safely treat rare and serious diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "SELB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.